Merck & Company (MRK)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-1995 | 12-1994 | 12-1993 | 12-1992 | 12-1991 | |
| Sales | 16,681,100 | 14,969,800 | 10,498,200 | 9,662,500 | 8,602,700 |
| Cost of Goods | 7,456,300 | 5,962,700 | 2,497,600 | 2,096,100 | 1,934,900 |
| Gross Profit | 9,224,800 | 9,007,100 | 8,000,600 | 7,566,400 | 6,667,800 |
| Operating Expenses | 4,629,500 | 4,908,400 | 4,087,300 | 4,075,000 | 3,559,000 |
| Operating Income | 4,595,600 | 4,099,399 | 3,913,900 | 3,491,500 | 3,109,700 |
| Other Income | 201,600 | 315,801 | -811,200 | 72,100 | 57,000 |
| Pre-tax Income | 4,797,200 | 4,415,200 | 3,102,700 | 3,563,600 | 3,166,700 |
| Income Tax | 1,462,000 | 1,418,200 | 936,500 | 1,117,000 | 1,045,000 |
| Net Income Continuous | 3,335,200 | 2,997,000 | 2,758,200 | 2,485,500 | 2,121,700 |
| Net Income Discontinuous | 0 | 0 | 0 | -462,400 | 0 |
| Net Income | $3,335,200 | $2,997,000 | $2,166,200 | $1,984,200 | $2,121,700 |
| EPS Basic Total Ops | 1.35 | 1.19 | 0.94 | 0.86 | 0.91 |
| EPS Basic Continuous Ops | 1.35 | 1.19 | 2.20 | 2.17 | 1.83 |
| EPS Basic Discontinuous Ops | N/A | N/A | N/A | -0.40 | N/A |
| EPS Diluted Total Ops | 1.35 | 1.19 | 0.94 | 1.73 | 1.83 |
| EPS Diluted Continuous Ops | 1.35 | 1.19 | 2.20 | 2.17 | 1.83 |
| EPS Diluted Discontinuous Ops | N/A | N/A | N/A | -0.40 | N/A |
| EBITDA(a) | $5,262,800 | $4,781,000 | $4,300,400 | $3,812,900 | $3,373,500 |